MyAverix Finance
HK · Healthcare
JBM (Healthcare) Limited (2161)
Drug Manufacturers - Specialty & Generic
JBM (Healthcare) Limited (2161) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $1.97B, P/E ratio is 8.93, net margin is 26.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2161
JBM (Healthcare) Limited (2161) — FAQ
What is JBM (Healthcare) Limited's market cap?
JBM (Healthcare) Limited (2161) has a reported market cap of $1.97B (data as of 2026-05-21).
What is 2161's P/E ratio?
The price-to-earnings (P/E) ratio for JBM (Healthcare) Limited (2161) is 8.93 (data as of 2026-05-21).
Does JBM (Healthcare) Limited pay a dividend?
Dividend yield is not available in the current snapshot for JBM (Healthcare) Limited (2161). Check the MyAverix Finance app for the latest dividend data.
What sector is JBM (Healthcare) Limited in?
JBM (Healthcare) Limited (2161) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 2161 listed on?
2161 is listed on HK.
What is JBM (Healthcare) Limited's net margin?
JBM (Healthcare) Limited (2161) reports a net margin of 26.6% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.